Akebia Therapeutics, Inc. (AKBA)
0.5669
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.5635
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Market Cap : 154.05M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 154.05M |
| October 22, 2026 | 152.77M |
| October 21, 2026 | 159.05M |
| October 20, 2026 | 167.96M |
| October 19, 2026 | 184.81M |
| October 16, 2026 | 182.07M |
| October 15, 2026 | 189.00M |
| October 14, 2026 | 190.76M |
| October 13, 2026 | 209.24M |
| October 12, 2026 | 214.73M |
| October 09, 2026 | 217.69M |
| October 08, 2026 | 221.42M |
| October 07, 2026 | 237.34M |
| October 06, 2026 | 238.73M |
| October 05, 2026 | 247.42M |
| October 02, 2026 | 235.06M |
| October 01, 2026 | 236.69M |
| September 30, 2026 | 250.00M |
| September 29, 2026 | 240.79M |
| September 28, 2026 | 242.69M |
| September 25, 2026 | 243.54M |
| September 24, 2026 | 249.73M |
| September 23, 2026 | 253.43M |
| September 22, 2026 | 266.31M |
| September 21, 2026 | 255.03M |
| Date | Value |
|---|---|
| September 18, 2026 | 248.83M |
| September 17, 2026 | 243.35M |
| September 16, 2026 | 249.41M |
| September 15, 2026 | 245.38M |
| September 14, 2026 | 261.66M |
| September 11, 2026 | 258.62M |
| September 10, 2026 | 257.20M |
| September 09, 2026 | 259.22M |
| September 08, 2026 | 279.90M |
| September 04, 2026 | 264.87M |
| September 03, 2026 | 267.20M |
| September 02, 2026 | 266.39M |
| September 01, 2026 | 256.72M |
| August 31, 2026 | 249.68M |
| August 28, 2026 | 238.75M |
| August 27, 2026 | 255.38M |
| August 26, 2026 | 246.33M |
| August 25, 2026 | 260.44M |
| August 24, 2026 | 244.73M |
| August 21, 2026 | 246.36M |
| August 20, 2026 | 249.84M |
| August 19, 2026 | 240.60M |
| August 18, 2026 | 231.47M |
| August 17, 2026 | 233.70M |
| August 14, 2026 | 237.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Emergent BioSolutions, Inc. | 319.60M |
| Exelixis, Inc. | 16.06B |
| ADMA Biologics, Inc. | 2.407B |
| Arcutis Biotherapeutics, Inc. | 3.918B |
| Relay Therapeutics, Inc. | 3.973B |
Market Cap Related Metrics
| PS Ratio | 0.6964 |
| Price to Book Value | 6.157 |
| Price to Free Cash Flow | 3.789 |
| Price | 0.5669 |
| Earnings Yield | -19.58% |